The "ETO" Lab

Take a look at our latest research on gut #microbiota and metabolites, published with @SpringerNature in @NatureCancer: rdcu.be/du20J Huge thanks to our collaboration partners @crc1371!

We've moved! Find us on Insta: as @guardian.re instagram.com/guardian.re?ig…

Find us on Insta: instagram.com/guardian.re?ig…

🩺 Dr. Erik T. Orberg gave a great talk about the microbiome as a biomarker and therapeutic agent in immuno-oncology, which garnered a lot of questions and discussion.

It’s been an innovative and inspiring day at the 6th Oncology Symposium @leukaemielabor with new insights into "From Biomarkers to Therapy"!

🧬 Join us for the 6th Oncology Symposium on Nov 8, 2024, under the theme "From Biomarkers to Therapy"! 📍 Attend in-person @leukaemielabor or online 💻 Discounted virtual tickets: €29 w/ code OS2024VIP 🩺 Sessions on pathology, oncology & more Limited seats—register now!

It's been an enriching and inspiring @KeystoneSymp conference on Microbiota and Cancer Immunity!

An incredible line-up of world-renowned speakers at #GvHGvL2024 in Regensburg.

This is an excellent paper by Czech and colleagues on regulatory neutrophils expressing Lipocalin-2 in GvHD. I'm thrilled to have been part of this exciting collaboration! science.org/doi/10.1126/sc…

Success is never achieved alone. It's the result of the collective effort of those who motivate and support us along the way. A special thanks to Ernst Holler and especially @HendrikPoeck for their supervision throughout this project!

We would like to express our gratitude to our collaborators - @vandenBrinkLab, @kaehde, @deng_lab, @crc1371 and many others for their valuable and and expert contributions. Their efforts have been crucial to the success of our project.

Our paper in @NatureCancer was featured in @SpringerNature 's Research Briefings, a one-page overview of the work, plus comments on its significance from independent experts and editors. Read here: rdcu.be/dwNdr

@GMFHx Thanks for the mention! The paper was just featured in @SpringerNature's Research Briefings, a one-page overview of the work, plus comments on its significance from independent experts and editors. Check out here: rdcu.be/dwNdr

The microbiome is a predictor of clinical outcomes in patients receiving allogeneic hematopoietic stem cell transplantation. New findings identify a microbiome signature associated with protective immunomodulatory metabolites: nature.com/articles/s4301…

@crc1371 @NatureCancer @HendrikPoeck @deng_lab Thanks for the mention! The paper was just featured in @SpringerNature's Research Briefings, a one-page overview of the work, plus comments on its significance from independent experts and editors. Check out here: rdcu.be/dwNdr

Fantastic paper on #gvhd just published in @NatureCancer by Eric T. Orberg @matrixat @HendrikPoeck, @deng_lab and many more @crc1371 members! Great team effort!

Researchers discovered that certain combinations of #gutbacteria protect #stemcelltransplantation patients and reduce the risk of graft versus host disease: go.tum.de/254522 #microbiome #immunereactions 📷S.Jarosch, D.Busch

@Jarosch_S @CellRepMed Congratulations Sebastian, and thanks for the excellent collaboration!

@Fischer_J_C @FischerRIOLab @SE_Combs @HeideggerS_MD Gratuliere Julius!

Many thanks to @SE_Combs for the great support, @HeideggerS_MD for the scientific input and especially Julia Gißibl, who performed the preliminary experiments for my Else Kröner Memorial grant application!